TAIPEI, Aug. 7, 2023 /PRNewswire/ — Specializing in EV solution integration, Taiwan-based automotive design company Cruise10 introduced its XP e-Cab EV chassis for delivery trucks that brings a vertical collaboration business model for automotive makers and high-tech industry companies….
Month: August 2023
DENVER, Aug. 7, 2023 /PRNewswire/ — Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm with $5.8 billion of assets under management, announced today that it has completed the successful fundraising for Revelstoke Capital Partners Fund III, L.P. (“RCP Fund…
The global business mentoring and coaching organization will move from its current location in East Brunswick to a new building in Eatontown this fall EAST BRUNSWICK, N.J. , Aug. 7, 2023 /PRNewswire/ — CEO Warrior, a global business mentoring, training and coaching organization for…
Updates 2023 Financial Guidance and Long-Term Targets Second Quarter Revenue of $103.2 million, up 6% Year-over-Year; Net Income of $89.8 million; and Adjusted EBITDA(1) of $44.1 million, up 7% Year-Over-Year BROOMFIELD, Colo., Aug. 7, 2023 /PRNewswire/ — Gogo Inc. (NASDAQ: GOGO) (“Gogo”…
RADNOR, Pa., Aug. 7, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a late-stage biopharmaceutical company, today announced that it will release its second quarter 2023 financial results after the market closes on Monday, August 14,…
RADNOR, Pa., Aug. 7, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a late-stage biopharmaceutical company, today announced that it will release its second quarter 2023 financial results after the market closes on Monday, August 14,…
NRx has Licensed US Patent 8,653,120 for use of D-Cycloserine to treat Chronic Pain Dr. Vania Apkarian, a world leader in pain and D-Cycloserine (DCS) research, has joined the NRx Scientific Advisory Board RADNOR, Pa., Aug. 7, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)…
NRx has Licensed US Patent 8,653,120 for use of D-Cycloserine to treat Chronic Pain Dr. Vania Apkarian, a world leader in pain and D-Cycloserine (DCS) research, has joined the NRx Scientific Advisory Board RADNOR, Pa., Aug. 7, 2023 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)…
CHICAGO, Aug. 7, 2023 /PRNewswire/ — In the near future, the blood culture tests industry is poised for remarkable advancements driven by cutting-edge technologies and innovative research. With a growing emphasis on personalized medicine and rapid diagnostic solutions, blood culture…
CHICAGO, Aug. 7, 2023 /PRNewswire/ — In the near future, the blood culture tests industry is poised for remarkable advancements driven by cutting-edge technologies and innovative research. With a growing emphasis on personalized medicine and rapid diagnostic solutions, blood culture…